GlassScriptPhysician profile
Lauren E Collin
NPI 1568836773
$2,103.73
in general payments reported to CMS, 2019-2025
13 companies · $762 in 2025
The $762 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $565 · 2022: $274 · 2023: $63.63 · 2024: $439 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,047.27 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $389.18 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Jazz Pharmaceuticals INC. | $127.72 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $112.47 | 2022-2024 | Dupixent |
| Inspire Medical Systems, INC. | $95.60 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.33 | 2022-2025 | Ofev, Jascayd |
| Verona Pharma, INC. | $46.94 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $43.94 | 2021 | |
| Insmed, INC. | $39.14 | 2025 | Arikayce |
| Mallinckrodt Hospital Products INC. | $29.46 | 2023 | Acthar |
| Sunovion Pharmaceuticals INC. | $28.67 | 2021 | |
| Amgen INC. | $27.83 | 2025 | Tezspire |
| Axsome Therapeutics, INC. | $22.18 | 2024 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Collin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.